NxStage Medical (NXTM) Reports Q4 Loss of $0.19, Beats by 1c; Guides Q1, FY10
Tweet Send to a Friend
NxStage Medical, Inc. (NASDAQ: NXTM) reports Q4 loss of $0.19, 1 cent better than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
